Drug Developed With AI Set To Start Clinical Trials | Unite.AI
The AI startup Exscientia created a new drug compound that will soon start undergoing clinical trials in Japan. This is one of just a few instances of AI developed rugs being used in a clinical setting, potentially bringing the world closer to the widespread use of AI in drug development and deployment. The new compound was developed in association with Sumitomo Dainippon Pharma and in contrast, to traditionally develope drugs, the AI-developed compound will be starting clinical trials in just under a year from the inception of the project. Typical drug development takes around four and a half years.